Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide

Single Arc Volumetric Modulated Arc Therapy for Complex Brain Gliomas: Is There an Advantage as Compared to Intensity Modulated Radiotherapy or by Adding a Partial Arc?

(2012) M. T. M. Davidson et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Radiotherapy Planning in High-grade Gliomas: a Survey of Current UK Practice

(2011) A.L. Creak et al.   CLINICAL ONCOLOGY

The Concepts, Diagnosis and Management of Early Imaging Changes after Therapy for Glioblastomas

(2011) P. Sanghera et al.   CLINICAL ONCOLOGY

Patterns and Timing of Recurrence After Temozolomide-Based Chemoradiation for Glioblastoma

(2010) Michael T. Milano et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Associated Brainstem Injury

(2010) Charles Mayo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Dose–Volume Effects of Optic Nerves and Chiasm

(2010) Charles Mayo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Radiation Dose–Volume Effects in the Brain

(2010) Yaacov Richard Lawrence et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Pattern of Failure After Limited Margin Radiotherapy and Temozolomide for Glioblastoma

(2010) Mark W. McDonald et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide

(2010) Giuseppe Minniti et al.   RADIOTHERAPY AND ONCOLOGY

Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation WithMGMTPromoter Methylation Status

(2009) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

IDH1andIDH2Mutations in Gliomas

(2009) Hai Yan et al.   NEW ENGLAND JOURNAL OF MEDICINE